New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy

In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. This guideline contains recommendations for diagnostics in primary membranous nephropathy, an autoimmune kidney disease that is characterised in most cases by the occurrence of autoantibodies against PLA2R and/or THSD7A. The […]